Sector Gamma As Ironwood Pharmaceuticals Inc Transaction History

Sector Gamma As

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$14.31 - $17.65 $6.07 Million - $7.48 Million	-423,850 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$11.83 - $16.2 $8.25 Million - $11.3 Million	-697,285 Reduced 62.19%	423,850 $8.1 Million
Q1 2018 May 09, 2018	SELL	$11.13 - $13.63 $750,362 - $918,907	-67,418 Reduced 5.67%	1,121,135 $17.3 Million
Q4 2017 Feb 12, 2018	SELL	$12.16 - $14.58 $7.74 Million - $9.28 Million	-636,449 Reduced 34.87%	1,188,553 $17.8 Million
Q3 2017 Nov 07, 2017	SELL	$12.07 - $14.87 $97,706 - $120,372	-8,095 Reduced 0.44%	1,825,002 $28.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,833,097	1,833,097 $34.6 Million

247

170M

11.2M

28.5K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $636M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.